Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in …
Markets fluctuated sharply within a range and ended up losing nearly half a percent on Wednesday, wiping out the gains from the preceding session. In today’s trade, shares of Nykaa, …
Promising trials of a new antibiotic drug trademarked as Zaynich – meant to act against all major superbugs – has triggered a sharp run-up in the Wockhardt stock. It has …